Gossamer Bio, Inc. (GOSS)
11.17
-0.26
(-2.27%)
USD |
NASDAQ |
Nov 19, 16:00
11.17
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Price : 11.17 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 11.00 | 11.58 | 10.95 | 11.43 | 242689.0 |
| Nov 17, 2026 | 10.85 | 11.45 | 10.22 | 11.04 | 221749.0 |
| Nov 16, 2026 | 10.88 | 11.40 | 10.76 | 10.98 | 207148.0 |
| Nov 13, 2026 | 11.19 | 11.40 | 10.60 | 10.97 | 124141.0 |
| Nov 12, 2026 | 11.27 | 12.15 | 10.60 | 11.24 | 188995.0 |
| Nov 11, 2026 | 9.76 | 11.94 | 9.71 | 11.69 | 335917.0 |
| Nov 10, 2026 | 10.52 | 11.54 | 10.42 | 11.28 | 100312.0 |
| Nov 09, 2026 | 9.93 | 11.58 | 9.545 | 10.64 | 234666.0 |
| Nov 06, 2026 | 9.27 | 9.99 | 9.27 | 9.77 | 84733.00 |
| Nov 05, 2026 | 9.77 | 9.77 | 8.91 | 9.42 | 151768.0 |
| Nov 04, 2026 | 9.42 | 10.04 | 9.42 | 9.95 | 115906.0 |
| Nov 03, 2026 | 9.38 | 9.68 | 8.80 | 9.28 | 139438.0 |
| Nov 02, 2026 | 10.30 | 10.35 | 9.30 | 9.45 | 190788.0 |
| Oct 30, 2026 | 10.56 | 10.75 | 10.17 | 10.38 | 179494.0 |
| Oct 29, 2026 | 10.70 | 11.08 | 10.48 | 10.69 | 108746.0 |
| Oct 28, 2026 | 9.61 | 10.88 | 9.45 | 10.69 | 186040.0 |
| Oct 27, 2026 | 9.17 | 9.87 | 9.10 | 9.77 | 138044.0 |
| Oct 26, 2026 | 9.61 | 9.644 | 8.68 | 9.15 | 250873.0 |
| Oct 23, 2026 | 9.40 | 9.77 | 9.00 | 9.605 | 144834.0 |
| Oct 22, 2026 | 9.73 | 9.965 | 9.34 | 9.46 | 190612.0 |
| Oct 21, 2026 | 9.50 | 10.39 | 9.50 | 9.79 | 218976.0 |
| Oct 20, 2026 | 8.41 | 9.625 | 8.29 | 9.58 | 214553.0 |
| Oct 19, 2026 | 8.80 | 8.885 | 8.310 | 8.43 | 181016.0 |
| Oct 16, 2026 | 8.88 | 8.995 | 8.510 | 8.77 | 171143.0 |
| Oct 15, 2026 | 8.86 | 9.18 | 8.73 | 8.89 | 197801.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| United Therapeutics Corp. | 559.07 |
| Arbutus Biopharma Corp. | 4.085 |
| ACADIA Pharmaceuticals, Inc. | 17.59 |
| Alnylam Pharmaceuticals, Inc. | 147.82 |
| Anika Therapeutics, Inc. | 13.29 |
Price Related Metrics
| PS Ratio | 0.5839 |
| Earnings Yield | -412.8% |
| Market Cap | 68.32M |